VS-014

N/A

Report date: 2025/03/12 16:39:04
NME

Base Information

Drug NameVS-014
Drug Alias NameVS014
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulatorsSodium/hydrogen exchanger 3 modulatorsSolute carrier family 26 member 9 modulators +[4] 
TargetsCystic fibrosis transmembrane conductance regulatorSodium/hydrogen exchanger 3Solute carrier family 26 member 9 +[4] 
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiomedical Advanced Research And Development AuthorityUniversity Of Florida Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuvara Therapeutics
Inactive CompaniesN/A
Active IndicationsDiarrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A